Home

KURT WHEELER

CIK 1252525 · last filed 2019-02-11

KURT WHEELER is a corporate insider who has filed 58 SEC Form 4 insider transactions across 14 companies since 2007. The most recent filing, for GMED, was dated Feb 11, 2019. Across all open-market trades the lifetime net is −$103.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.82M

Companies

14

Total Filings

58

Lifetime Open-Market Net

-$103.85M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GMED Director 44,319 $86.25 $3.82M -$90.17M 13 2019-02-11
Radius Health, Inc. (RDUS) Delisted 2,459,804 $30.00 $73.79M $0 1 2016-09-29
Oxford Immunotec Global PLC (OXFD) Delisted 10%+ Owner 2,237,377 — — -$8.32M 2 2015-06-17
Pernix Sleep, Inc. (SOMX) Delisted Director 3,807,612 — — -$1.82M 14 2012-07-02
ZOGENIX, INC. (ZGNX) Delisted Director 5,982,439 $26.68 $159.61M $7.00M 4 2012-06-06
ReShape Weightloss Inc. (ETRM) Delisted 1,669,753 — — $0 1 2010-12-15
ARYx Therapeutics, Inc. (ARYX) Delisted 10%+ Owner — — — $0 1 2010-10-04
SENORX INC (SENO) Delisted Director 2,032,475 — — -$2.77M 6 2010-06-29
AVEO PHARMACEUTICALS, INC. (AVEO) Delisted 2,208,961 $15.00 $33.13M $0 1 2010-03-18
Pharmasset Inc (VRUS) Delisted 10%+ Owner 4,061 — — -$2.19M 1 2008-02-11
HEMOSENSE INC (HEM) Delisted Director 4,003,119 — — -$6.07M 3 2007-11-07
CRYOCOR INC (CRYO) Delisted Director 3,028,082 — — $496.3K 2 2007-05-15
CORNERSTONE THERAPEUTICS INC (CRTX) Delisted 3,846,328 $1.95 $7.50M $0 1 2007-02-15
COTHERIX INC (CTRX) Delisted 10%+ Owner 0 — — $0 1 2007-01-10

Recent Filings

58 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-02-11 GMED Grant (A) — $0 EDGAR
2018-01-24 GMED Grant (A) — $0 EDGAR
2017-02-01 GMED Grant (A) — $0 EDGAR
2016-09-29 Radius Health, Inc. (RDUS) Delisted Other (J) −3,689,706 $0 EDGAR
2016-01-27 GMED Grant (A) — $0 EDGAR
2016-01-06 GMED Mixed — -$186.0K EDGAR
2015-06-17 Oxford Immunotec Global PLC (OXFD) Delisted Sell (S) −329,840 -$4.72M EDGAR
2015-06-12 Oxford Immunotec Global PLC (OXFD) Delisted Sell (S) −252,784 -$3.61M EDGAR
2015-01-22 GMED Grant (A) — $0 EDGAR
2014-01-27 GMED Grant (A) — $0 EDGAR
Showing 1–10 of 58
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.